A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence

被引:121
作者
Temple, Jonathan L. [1 ]
Cordero, Paul [2 ]
Li, Jiawei [2 ]
Vi Nguyen [2 ]
Oben, Jude A. [2 ,3 ]
机构
[1] Kings Coll London, Fac Life Sci & Med, London WC2R 2LS, England
[2] UCL, Inst Liver & Digest Hlth, Rowland Hill St, London NW3 2PF, England
[3] NHS Fdn Trust, Guys & St Thomas Hosp, Dept Gastroenterol & Hepatol, Westminster Bridge Rd, London SE1 7EH, England
关键词
NAFLD; steatosis; obesity; children; adolescent; PLACEBO-CONTROLLED TRIAL; OBESE CHILDREN; METABOLIC SYNDROME; HEPATIC STEATOSIS; VITAMIN-E; URSODEOXYCHOLIC ACID; INSULIN-RESISTANCE; LIFE-STYLE; AMINOTRANSFERASE LEVELS; PEDIATRIC-PATIENTS;
D O I
10.3390/ijms17060947
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-Alcoholic Fatty Liver Disease (NAFLD) is now the most prevalent form of chronic liver disease, affecting 10%-20% of the general paediatric population. Within the next 10 years it is expected to become the leading cause of liver pathology, liver failure and indication for liver transplantation in childhood and adolescence in the Western world. While our understanding of the pathophysiological mechanisms underlying this disease remains limited, it is thought to be the hepatic manifestation of more widespread metabolic dysfunction and is strongly associated with a number of metabolic risk factors, including insulin resistance, dyslipidaemia, cardiovascular disease and, most significantly, obesity. Despite this, "paediatric" NAFLD remains under-studied, under-recognised and, potentially, undermanaged. This article will explore and evaluate our current understanding of NAFLD in childhood and adolescence and how it differs from adult NAFLD, in terms of its epidemiology, pathophysiology, natural history, diagnosis and clinical management. Given the current absence of definitive radiological and histopathological diagnostic tests, maintenance of a high clinical suspicion by all members of the multidisciplinary team in primary and specialist care settings remains the most potent of diagnostic tools, enabling early diagnosis and appropriate therapeutic intervention.
引用
收藏
页数:36
相关论文
共 190 条
  • [21] Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria
    Boyraz, Mehmet
    Hatipoglu, Nihal
    Sari, Erkan
    Akcay, Arzu
    Taskin, Necati
    Ulucan, Korkut
    Akcay, Teoman
    [J]. OBESITY RESEARCH & CLINICAL PRACTICE, 2014, 8 (04) : E356 - E363
  • [22] Boyraz M, 2013, BIOMARK MED, V7, P423, DOI [10.2217/BMM.13.14, 10.2217/bmm.13.14]
  • [23] Accelerated Infant Weight Gain and Risk for Nonalcoholic Fatty Liver Disease in Early Adulthood
    Breij, Laura M.
    Kerkhof, Gerthe F.
    Hokken-Koelega, Anita C. S.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (04) : 1189 - 1195
  • [24] Obesity and hepatocellular carcinoma
    Caldwell, SH
    Crespo, DM
    Kang, HS
    Al-Osaimi, AMS
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S97 - S103
  • [25] Recent advancements in drug treatment of obesity
    Carter, Rebeca
    Mouralidarane, Angelina
    Ray, Shuvra
    Soeda, Junpei
    Oben, Jude
    [J]. CLINICAL MEDICINE, 2012, 12 (05) : 456 - 460
  • [26] The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Diehl, Anna Mae
    Brunt, Elizabeth M.
    Cusi, Kenneth
    Charlton, Michael
    Sanyal, Arun J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (06) : 811 - 826
  • [27] A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C
    Charlotte, Frederic
    Le Naour, Gilles
    Bernhardt, Carole
    Poynard, Thierry
    Ratziu, Vlad
    [J]. HUMAN PATHOLOGY, 2010, 41 (08) : 1178 - 1185
  • [28] Chavez-Tapia NC, 2010, COCHRANE DATABASE SY, V1
  • [29] Hepatic triglyceride synthesis and nonalcoholic fatty liver disease
    Choi, Steve S.
    Diehl, Anna Mae
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2008, 19 (03) : 295 - 300
  • [30] Supplementation with methyl donors during lactation to high-fat-sucrose-fed dams protects offspring against liver fat accumulation when consuming an obesogenic diet
    Cordero, P.
    Milagro, F. I.
    Campion, J.
    Martinez, J. A.
    [J]. JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, 2014, 5 (05) : 385 - 395